RxDoctor Payments DataLook up a doctor →

Xofluza: payments to doctors

Payments that named Xofluza as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.1M
Providers
35,387
Transactions
71,824
Average per transaction
$30

The per-transaction average — $30 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 35,387 providers the average total is $60, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genentech USA, Inc.$1,935,91390.7%
Genentech, Inc.$118,3015.5%
F. Hoffmann-la Roche AG$51,4302.4%
Shionogi Inc$14,5410.7%
Roche Products Limited$13,4100.6%
← All drugs & devices